CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on January 20, 2012
Apollo Medical Holdings, Inc.
450 North Brand Blvd., Suite 600
Glendale, CA 94118
Tel: 818-396-8050
Fax: 818-291-6444
FILE NO. 000-25809
January 20, 2012
United States Securities and Exchange Commission
Washington DC 90549
Attention: Mr. John Reynolds
Dear Sirs:
re: | Apollo Medical Holdings, Inc. (“ApolloMed” or the “Company”) - Comment Letter Dated January 9, 2012 |
I have received and reviewed your letter dated January 9, 2012 with respect to your review of our filings. As discussed with Steve Lo and John Archfield on January 19, 2012, the Company is currently using all reasonable efforts to prepare a response, but it would be unduly burdensome for the Company to respond by January 23, 2011. I am hereby advising you that the Company intends to provide a response to your comments on or prior to February 6, 2012.
Please feel free to call me if you have any questions.
Very truly yours,
Kyle Francis
Chief Financial Officer
Apollo Medical Holdings, Inc.
Tel: 917-676-3886
kfrancis@apollomed.net